Summary
- Ceftaroline (Zinforo°, AstraZeneca) is a new cephalosporin intended for intravenous administration (as ceftaroline fosamil). It is authorised for the treatment of community-acquired pneumonia and for serious infections of the skin and soft tissues.
- In practice, there is no proof that ceftaroline represents a therapeutic advance for patients with community-acquired pneumonia warranting hospitalisation or with serious skin or soft-tissue infections. It is best to stick with better-known antibiotics.
Full text available for free download.
©Prescrire 1 December 2013
"Ceftaroline fosamil" Prescrire Int 2013; 22 (144): 291. (Pdf, free)